Tau load in the AD brain has previously been shown to be associated with levels of Aβ1-40—the primary Aβ species in CAA plaques—but not Aβ1-42, and it was suggested that the p-tau pathology here is a consequence of microglial processing of excess Aβ1-40 [316]. This evidence concerns the gene MAPT and Alzheimer disease.